Tetrahydrothiophene-3-ol-1,1-dioxide, 95.0%, 2.5g

(3R)-4-methyl-3-morpholinecarboxylic acid hydrochloride, 95.0%, 250mg

Long working distance plan Fluarex 4x/0.13 infinity corrected IOS objective, corrected for 1 mm petri dish thickness

2,5-Dimethoxy-4-propylbenzaldehyde, 95.0%, 1g

TERT-BUTYL (2R,3S)-3-HYDROXY-2-METHYLAZETIDINE-1-CARBOXYLATE, 95%, 5g

5'-Fluoro-2'-methoxyacetophenone, 95.0%, 500g

tert-Butyl 2',6'-dichloro-5,6-dihydro-[4,4'-bipyridine]-1(2H)-carboxylate, 97.0%, 250mg

4-Amino-4H-1,2,4-triazole-3-thiol, 97.0%, 5g

1-(Thieno[3,2-d]pyrimidin-4-yl)piperidine-4-carbaldehyde, 97%, 1g

1-(2,4-difluorobenzoyl)-1,4-diazepane, 95.0%, 2g

Oxazole-4-carbonitrile, 95.0%, 1g

4-(4H-1,2,4-Triazol-4-yl)phenol, 95.0%, 5g

2-CHLORO-N-METHYL-5-(TRIFLUOROMETHYL)PYRIMIDIN-4-AMINE, 95.0%, 1g